Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumor: being younger and getting less benefit from adjuvant tamoxifen treatment

被引：0
|
作者：
Yu, K. [1 ]
Di, G. [1 ]
Wu, J. [1 ]
Lu, J. [1 ]
Shen, K. [1 ]
Shen, Z. [1 ]
Shao, Z. [1 ]
机构：
[1] Fudan Univ, Canc Hosp Canc Inst, Dept Breast Surg, Shanghai 200433, Peoples R China
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 07期
关键词：
D O I：
10.1016/S1359-6349(08)70759-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：182 / 182
页数：1
相关论文
共 50 条
  • [1] Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumor: Being younger and getting less benefit from adjuvant tamoxifen treatment
    Yu, K., Sr.
    Di, G.
    Shao, Z.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment
    Ke-da Yu
    Gen-hong Di
    Jiong Wu
    Jin-song Lu
    Kun-wei Shen
    Guang-yu Liu
    Zhen-zhou Shen
    Zhio-Ming Shao
    Journal of Cancer Research and Clinical Oncology, 2008, 134 : 1347 - 1354
  • [3] Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment
    Yu, Ke-da
    Di, Gen-hong
    Wu, Jiong
    Lu, Jin-song
    Shen, Kun-wei
    Liu, Guang-yu
    Shen, Zhen-zhou
    Shao, Zhio-ming
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2008, 134 (12) : 1347 - 1354
  • [4] Survival Benefit of Tamoxifen in Estrogen Receptor-Negative and Progesterone Receptor-Positive Low Grade Breast Cancer Patients
    Yang, Li-Heng
    Tseng, Hsin-Shun
    Lin, Che
    Chen, Li-Sheng
    Chen, Shou-Tung
    Kuo, Shou-Jen
    Chen, Dar-Ren
    JOURNAL OF BREAST CANCER, 2012, 15 (03) : 288 - 295
  • [5] Characterization of estrogen receptor-negative/progesterone receptor-positive breast cancer
    Shen, Tiansheng
    Brandwein-Gensler, Margaret
    Hameed, Omar
    Siegal, Gene P.
    Wei, Shi
    HUMAN PATHOLOGY, 2015, 46 (11) : 1776 - 1784
  • [6] Natural history of estrogen receptor-negative, progesterone receptor-positive breast cancer
    Nikoic-Vukosavljevic, D
    Kanjer, K
    Neskovic-Konstantinovic, Z
    Vukotic, D
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2002, 17 (03): : 196 - 200
  • [7] Estrogen receptor-positive, progesterone receptor-negative breast cancer: Association with growth factor receptor expression and tamoxifen resistance
    Arpino, G
    Weiss, H
    Lee, AV
    Schiff, R
    De Placido, S
    Osborne, CK
    Elledge, RM
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (17): : 1254 - 1261
  • [8] Low RAB6C expression is a predictor of tamoxifen benefit in estrogen receptor-positive/progesterone receptor-negative breast cancer
    Fohlin, Helena
    Bekkhus, Tove
    Sandstrom, Josefine
    Fornander, Tommy
    Nordenskjold, Bo
    Carstensen, John
    Stal, Olle
    MOLECULAR AND CLINICAL ONCOLOGY, 2020, 12 (05) : 415 - 420
  • [9] Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer
    Garcia, Ximena
    Elia, Andres
    Galizzi, Lucrecia
    May, Maria
    Spengler, Eunice
    Martinez Vazquez, Paula
    Burruchaga, Javier
    Gass, Hugo
    Lanari, Claudia
    Lamb, Caroline A.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (01) : 257 - 263
  • [10] Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer
    Ximena García
    Andrés Elía
    Lucrecia Galizzi
    María May
    Eunice Spengler
    Paula Martínez Vázquez
    Javier Burruchaga
    Hugo Gass
    Claudia Lanari
    Caroline A. Lamb
    Breast Cancer Research and Treatment, 2020, 180 : 257 - 263
12345